Cardiovascular Systems, Inc. Announces Closing Of Common Stock Offering And Full Exercise Of Underwriters’ Option To Purchase Additional Shares

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII) today announced the closing of its underwritten registered public offering of an aggregate of 3,000,000 shares of its common stock, including 391,304 shares of common stock sold pursuant to the full exercise by the underwriters of their option to purchase additional shares. All of the shares were sold at a price to the public of $30.00 per share. The aggregate net proceeds to the company from this offering are approximately $84.5 million, after deducting underwriting discounts and commissions and estimated offering expenses.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC